Lazar Dimitrov
Director/Miembro de la Junta en Lumos Pharma Sub, Inc. .
Cargos activos de Lazar Dimitrov
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Lumos Pharma Sub, Inc.
 Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | Director/Miembro de la Junta | - | - |
Historial de carrera de Lazar Dimitrov
Antiguos cargos conocidos de Lazar Dimitrov.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Clarus Ventures LLC
 Clarus Ventures LLC Investment ManagersFinance Clarus Ventures LLC (Clarus Ventures) is a venture capital subsidiary of Blackstone, Inc. founded in 2005 by Nicholas G. Galakatos. The firm is headquartered in Cambridge, Massachusetts. | Analista de Capital Privado | 07/01/2016 | - |
Formación de Lazar Dimitrov.
| Dartmouth College | Undergraduate Degree |
| University of Washington | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| Private Equity Analyst | 1 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectorial
| Consumer Services | 3 |
| Finance | 2 |
| Health Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Clarus Ventures LLC
Clarus Ventures LLC Investment ManagersFinance Clarus Ventures LLC (Clarus Ventures) is a venture capital subsidiary of Blackstone, Inc. founded in 2005 by Nicholas G. Galakatos. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Lumos Pharma Sub, Inc.
Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | Health Services |
- Bolsa de valores
- Insiders
- Lazar Dimitrov
- Experiencia
